Literature DB >> 606765

Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.

A P Kendal, G R Noble, W R Dowdle.   

Abstract

Vaccines prepared with influenza A/swine/1976/37-like virus contained neuraminidase activity comparable to that of H3N2 vaccines, whereas little neuraminidase activity could be detected in influenza A/New Jersey/76 vaccines. In single-dose vaccine studies, A/swine/1976/37-like split-virus vaccine induced antibody to neuraminidase (NAAb) in about 20% of children younger than 18 years and this NAAb response was better than or equal to the antibody response to the vaccine's hemagglutinin (HAAb). In immunologically primed adults, the NAAb response to a single dose of Hsw1N1 or H3N2 vaccine was 38%-54%, but this value was about 1.7-fold lower than that for HAAb response. Children six to 17 years old given two doses of A/swine/1976/37-like vaccine had an overall 70% NAAb response, whereas children of similar age had an overall 30%-48% NAAb response to two doses of A/Victoria/3/75 (H3N2) virus. The findings support a hypothesis that the NAAb response to influenza vaccines can be suppressed if subjects receiving the vaccine are immunologically primed to its hemagglutinin component. NAAb responses in the absence of HAAb responses occur in only about 5% of vaccinated persons who are immunologically primed to both the hemagllutinin and neuraminidase of the vaccine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 606765     DOI: 10.1093/infdis/136.supplement_3.s415

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.

Authors:  Judith D Easterbrook; Louis M Schwartzman; Jin Gao; John C Kash; David M Morens; Laura Couzens; Hongquan Wan; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  Virology       Date:  2012-06-22       Impact factor: 3.616

2.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

Review 3.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

4.  Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay.

Authors:  M W Khan; M Gallagher; D Bucher; C P Cerini; E D Kilbourne
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

5.  Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.

Authors:  A P Kendal; F M Bozeman; F A Ennis
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Neutralization test in influenza: use in individuals without hemagglutination inhibition antibody.

Authors:  P A Gross; A E Davis
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

7.  Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.

Authors:  Robert B Couch; Robert L Atmar; Wendy A Keitel; John M Quarles; Janet Wells; Nancy Arden; Diane Niño
Journal:  Vaccine       Date:  2012-10-26       Impact factor: 3.641

Review 8.  Purified viral neuraminidase vaccine to control influenza.

Authors:  D J Arora
Journal:  Can Med Assoc J       Date:  1979-12-22       Impact factor: 8.262

9.  A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Authors:  Glendie Marcelin; Rebecca DuBois; Adam Rubrum; Charles J Russell; Janet E McElhaney; Richard J Webby
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

10.  Risk Factors and Attack Rates of Seasonal Influenza Infection: Results of the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study.

Authors:  Q Sue Huang; Don Bandaranayake; Tim Wood; E Claire Newbern; Ruth Seeds; Jacqui Ralston; Ben Waite; Ange Bissielo; Namrata Prasad; Angela Todd; Lauren Jelley; Wendy Gunn; Anne McNicholas; Thomas Metz; Shirley Lawrence; Emma Collis; Amanda Retter; Sook-San Wong; Richard Webby; Judy Bocacao; Jennifer Haubrock; Graham Mackereth; Nikki Turner; Barbara McArdle; John Cameron; Edwin G Reynolds; Michael G Baker; Cameron C Grant; Colin McArthur; Sally Roberts; Adrian Trenholme; Conroy Wong; Susan Taylor; Paul Thomas; Jazmin Duque; Diane Gross; Mark G Thompson; Marc-Alain Widdowson
Journal:  J Infect Dis       Date:  2019-01-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.